Dr. FRANCESC E. BORRAS (BSc, PhD)
Dr. Francesc E. Borràs graduated in Biology at the University of Barcelona in 1991. His phD studies were supervised by Drs. Antonio Celada and Jorge LLoberas, and focused on cellular and molecular aspects of macrophages. In 1998 he joined the Dept. of Histocompatibility and Immunogenetics at the National Blood Service in London (UK) led by Dr. Cristina Navarrete, where he started to work on DC’s biology in tolerance as a post-doctoral fellow. In 2002, he earned a junior “Miguel Servet” researcher position and joined the Immunology lab at the “Germans Trias i Pujol” Research Institute (IGTP), directed by Dr. Ricardo Pujol, where he founded and led the Dendritic Cells´ research group (DCTeam).
After completing the “Miguel Servet” program – obtaining the highest category -level A-, in 2008 he was further promoted to a Senior Researcher position by the “Instituto de Salud Carlos III” and the “Generalitat de Catalunya” (Dept. of Health), and founded the IVECAT Group at the IGTP. Since 2014, Dr. Borràs is coordinator of the Research Group REMAR (from “Recerca en Malalties d’Afectació Renal”), a research group funded by “Generalitat of Catalonia” (2014SGR804), which includes health professionals with an interest in studying and addressing the problems of kidney diseases.
Over the past 10 years, the group has maintained two lines of research focusing respectively on the induction of tolerance and in extracellular vesicles or exosomes. Dr. Borràs has led several research projects, supervised several doctoral theses and participated in the publication of over 50 manuscripts.
Dr. Borràs has been member of the board of the Catalan Society for Immunology (2008-12), assistant professor of Immunology at the UAB (2004-2012) and Chief Editor of “Inmunología” (2010-13).
He is currently evaluator of ANEP, member of the Editorial Board of the “Journal of Extracellular Vesicles”, and joint member of the Management Committee of the COST ME-HAD action (http://www.mehad-cost.eu). Dr. Borràs is also co-founder and vice president of GEIVEX (Spanish Research Group on Extracellular Vesicles, geivex.org) and co-founder of “Innovex Therapeutics”, a spin-off devoted to harness clinical application of extracellular vesicles.
|Francesc E. BORRÀS SERRES Born in Barcelona,Sept 13th, 1965||Senior Researcher|
|Consolidated “Miguel Servet” Level A (2008)|
|EDUCATION AND TRAINING|
|Faculty of Biology||U. Barcelona||1991||BSc||Biology|
|Faculty of Biology||U. Barcelona||1994||Master||Immunology|
|Faculty of Biology||U. Barcelona||1998||PhD||Biology (Immunology)|
- 2008- to date – Group Leader at the “Germans Trias i Pujol” Research Institute (IGTP). Badalona, Spain
- 2014 – Coordinator “REMAR Group”.
- 2014 – Head of Research. Servei de Nefrologia. Hosp. Universitari Germans Trias i Pujol. Badalona, Spain
- 2010 – to date – Editor in Chief. “INMUNOLOGIA”, Journal of the Spanish Society for Immunology (SEI)
- 2012 – to date – Member. Editorial Board of the “Journal of Extracellular Vesicles”
- 2008-2012 – Member of the Board of the Catalan Society for Immunology (SCI)
- 2004-2012 – Assistant Professor Immunology (UAB)